Altria Group, Inc. Reports Strong Q1 2026 Results and Reaffirms Full-Year Guidance

RICHMOND, Va. – April 30, 2026 — Altria Group, Inc. (NYSE: MO) delivered a robust performance for the first quarter of 2026, signaling a positive outlook for the remainder of the year. The company reaffirmed its full-year guidance for adjusted diluted earnings per share (EPS), emphasizing strong operational execution, solid cash returns to shareholders, and continuing investments in its smoke-free vision.

Key Financial Highlights

• Adjusted Diluted EPS: Gained 7.3% year-over-year, reaching \$1.32 for Q1 2026 (from \$1.23 in Q1 2025). Reported diluted EPS doubled to \$1.30 (from \$0.63).
• Net Revenues: Increased by 3.2% to \$5.43 billion, primarily driven by the smokeable products segment.
• Revenues Net of Excise Taxes: Rose 5.3% to \$4.76 billion.
• Adjusted Effective Tax Rate: 23.1% (down 0.4 percentage points year-over-year).
• Operating Companies Income (OCI): Q1 2026 reported OCI surged 60.6% to \$3.03 billion, driven by higher pricing, tax refunds, and lower litigation costs.
• Share Repurchases: 4.5 million shares bought back at an average price of \$62.33 per share, totaling \$280 million. \$720 million remains under the current \$2 billion program (expires December 31, 2026).
• Dividends: \$1.8 billion paid out to shareholders in Q1 2026.

2026 Full-Year Guidance Reaffirmed

Altria reaffirmed its guidance for 2026 adjusted diluted EPS in the range of \$5.56 to \$5.72, representing a 2.5% to 5.5% growth from the 2025 base of \$5.42. The company expects EPS growth to be more balanced between the first and second halves of 2026, adjusting for moderated e-vapor industry growth, macroeconomic uncertainty, and planned investments in new capabilities and products.

• Guidance excludes certain items: losses on debt, restructuring charges, asset impairments, acquisition-related items, equity investment special items, specific tax items, litigation charges, and amortization of intangibles.
• Assumptions include: increased cigarette import/export activity, investments in contract manufacturing, NJOY ACE not returning to market in 2026, reinvestment of cost savings, and investments supporting the company’s Vision.

Segment Results

Smokeable Products

• Net Revenues: Up 2.9% to \$4.76 billion.
• Revenues Net of Excise Taxes: Up 5.2% to \$4.11 billion.
• Adjusted OCI: Up 6.3% to \$2.68 billion. Adjusted OCI margin improved to 65.1% (from 64.4%).
• Shipment Volume: Domestic cigarette volume down 2.4% (estimated 4% decline when adjusted for inventory movements). The industry as a whole saw a 5% decline. Cigar shipments nearly flat (down 0.2%).
• Marlboro: Retail share of total cigarette category decreased 1.4 points to 39.7%; premium segment share up 0.1 point to 59.5%. Discount brands’ share increased by 1.9 points, reflecting consumer downtrading amid income pressures.

Oral Tobacco Products

• Net Revenues: Up 2.3% to \$669 million. Revenues net of excise taxes up 2.9% to \$647 million.
• Adjusted OCI: Up 0.2% to \$436 million; adjusted OCI margin fell by 1.8 points to 67.4%.
• Shipment Volume: Decreased 3.1% (down 8.5% after inventory adjustment). The industry grew 9.5% over the last six months, driven by oral nicotine pouches.
• on! Nicotine Pouches: Retail share of total oral tobacco category at 7.8% (down 0.8 points year-over-year); share of nicotine pouch category at 13.4% (down 4.2 points).
• The U.S. nicotine pouch category now represents 58.1% of the oral tobacco market—a 9.1 point increase year-over-year.

Important Shareholder Information & Potential Price-Sensitive Developments

• Shareholder Returns: Significant capital returns via buybacks and dividends continue. The current share repurchase authorization has \$720 million available and expires year-end 2026, supporting capital allocation confidence.
• Guidance and Outlook: The reaffirmed and relatively robust full-year guidance, despite macroeconomic and regulatory headwinds, may be viewed as a signal of management’s confidence in the underlying business strength and strategic positioning.
• Risks & Uncertainties: The company explicitly notes ongoing risks including: regulatory actions (FDA, excise taxes), litigation, shifts in consumer behavior toward discount and illicit products, and macroeconomic pressures (inflation, disposable income).
• Product Innovation & Market Development: Altria continues to invest in smoke-free products and contract manufacturing. The absence of NJOY ACE from the market in 2026 is already factored into guidance, which may moderate expectations for the e-vapor recovery.
• Impairment and Special Items: The absence of large asset impairment charges (notably the \$873 million e-vapor goodwill write-off in Q1 2025) significantly boosts year-over-year comparability.

Strategic & Brand Portfolio Update

Altria is executing on its “Moving Beyond Smoking®” vision—transitioning adult smokers to smoke-free products, competing for existing smoke-free adult nicotine consumers, and exploring new growth opportunities beyond U.S. borders and nicotine. The portfolio includes leading brands such as Marlboro, Black & Mild, Copenhagen, Skoal, on!, and NJOY. The company maintains equity stakes in Anheuser-Busch InBev and Cronos Group, providing additional cash flow and diversification.

Balance Sheet & Liquidity

• Cash & Equivalents: \$3.53 billion at March 31, 2026.
• Total Debt: \$24.60 billion; net debt reduction from year-end 2025.
• Stockholders’ Equity: Negative at \$(3.21) billion, reflecting historical returns of capital and non-cash charges (common for tobacco companies with high payout ratios).

Forward-Looking Statements & Risks

Management highlighted numerous risk factors including regulatory uncertainty, litigation, macroeconomic pressures, the continued rise of illicit products, supply chain vulnerabilities, and the unpredictable trajectory of the e-vapor and smoke-free categories. Shareholders should remain cautious regarding regulatory and consumer trends, especially as the company’s results are sensitive to shifts in excise taxes, litigation outcomes, and changes in consumer spending.

Conclusion

Altria delivered a strong start to 2026, driving EPS growth, maintaining healthy cash flows, and returning significant capital to shareholders. The reaffirmed guidance and balanced approach to risk management and investment are likely to be viewed positively by investors. However, ongoing regulatory, market, and macroeconomic risks remain key considerations for the share price and future performance.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should review the company’s official filings and consult with their financial advisors before making investment decisions. The information in this article is based on Altria Group, Inc.’s Q1 2026 earnings release and may be subject to updates and revisions.

View ALTRIA GROUP, INC. Historical chart here